AP136F
Goat Anti-Rat IgG Antibody, FITC conjugate
26 mg/mL, Chemicon®
Iniciar sesiónpara Ver la Fijación de precios por contrato y de la organización
About This Item
Código UNSPSC:
12352203
eCl@ss:
32160702
NACRES:
NA.46
En este momento no podemos mostrarle ni los precios ni la disponibilidad
Productos recomendados
origen biológico
goat
Nivel de calidad
conjugado
FITC conjugate
forma del anticuerpo
F(ab′)2 fragment of affinity isolated antibody
tipo de anticuerpo
secondary antibodies
clon
polyclonal
reactividad de especies
rat
fabricante / nombre comercial
Chemicon®
concentración
26 mg/mL
técnicas
immunofluorescence: suitable
Condiciones de envío
wet ice
modificación del objetivo postraduccional
unmodified
Categorías relacionadas
Especificidad
Reacts with Rat IgG gamma chain, as well as the light chains from all rat immunoglobulin classes. Monospecific on IEP against whole rat serum. Single band on IEP at a concentration of 10 mg/mL when run against rabbit anti goat whole serum.
FLUOROPHORE/ PROTEIN:
Approximately 12 mg/mg.
FLUOROPHORE/ PROTEIN:
Approximately 12 mg/mg.
Inmunógeno
Highly purified Rat IgG isolated from pooled normal rat serum.
Aplicación
Goat anti-Rat IgG Antibody, FITC conjugate is an antibody against Rat IgG for use in IF.
Research Category
Secondary & Control Antibodies
Secondary & Control Antibodies
Research Sub Category
Whole Immunoglobulin Secondary Antibodies
Whole Immunoglobulin Secondary Antibodies
Almacenamiento y estabilidad
When protected from light, the lyophilized antibody conjugate is stable at 2-8°C.
DO NOT FREEZE.
DO NOT FREEZE.
Información legal
CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany
Cláusula de descargo de responsabilidad
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
¿No encuentra el producto adecuado?
Pruebe nuestro Herramienta de selección de productos.
Frases de peligro
Consejos de prudencia
Clasificaciones de peligro
Aquatic Chronic 3
Código de clase de almacenamiento
11 - Combustible Solids
Clase de riesgo para el agua (WGK)
WGK 3
Certificados de análisis (COA)
Busque Certificados de análisis (COA) introduciendo el número de lote del producto. Los números de lote se encuentran en la etiqueta del producto después de las palabras «Lot» o «Batch»
¿Ya tiene este producto?
Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.
Zheng Liu et al.
Redox biology, 52, 102305-102305 (2022-04-04)
Hepatocellular cell death and macrophage proinflammatory activation contribute to the pathology of various liver diseases, during which XBP1 plays an important role. However, the function and mechanism of XBP1 in thioacetamide (TAA)-induced acute liver injury (ALI) remains unknown. Here, we
Gioia Marino et al.
Science advances, 9(28), eadh1403-eadh1403 (2023-07-14)
Intensive physical activity improves motor functions in patients with Parkinson's disease (PD) at early stages. However, the mechanisms underlying the beneficial effects of exercise on PD-associated neuronal alterations have not been fully clarified yet. Here, we tested the hypothesis that
Shintaro Nakao et al.
The American journal of pathology, 171(3), 1058-1065 (2007-08-11)
Dexamethasone, a synthetic corticosteroid, is widely used as a potent anti-inflammatory drug in various diseases including corneal angiogenesis. However, dexamethasone's impact on interleukin (IL)-1beta-dependent inflammatory angiogenesis is unknown. Here, we show that dexamethasone inhibits IL-1beta-induced neovascularization and the expression of
Alessandro Tozzi et al.
Brain : a journal of neurology, 144(11), 3477-3491 (2021-07-24)
Misfolding and aggregation of α-synuclein are specific features of Parkinson's disease and other neurodegenerative diseases defined as synucleinopathies. Parkinson's disease progression has been correlated with the formation and extracellular release of α-synuclein aggregates, as well as with their spread from
J K L Woodward et al.
Eye (London, England), 19(3), 342-348 (2004-07-20)
To establish if invasive and noninvasive uveal melanomas have differences in expression of adhesion molecules, and whether their adhesive interactions with the extracellular matrix (ECM) and endothelium vary. Cells from an invasive and noninvasive uveal melanoma cell line and hepatic
Active Filters
Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.
Póngase en contacto con el Servicio técnico
